A. J. Neville

2.2k total citations · 1 hit paper
12 papers, 1.7k citations indexed

About

A. J. Neville is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, A. J. Neville has authored 12 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in A. J. Neville's work include Innovations in Medical Education (3 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). A. J. Neville is often cited by papers focused on Innovations in Medical Education (3 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). A. J. Neville collaborates with scholars based in Canada, New Zealand and United States. A. J. Neville's co-authors include Malcolm J. Moore, I. F. Tannock, Peter Venner, David Osoba, C Coppin, D. Scott Ernst, Martin R. Stockler, Jonathan J. Wilson, George Armitage and Geoffrey R. Norman and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Academic Medicine.

In The Last Decade

A. J. Neville

12 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1996 1.2k citations I. F. Tannock, David Osoba et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. J. Neville Canada	9	1.2k	574	310	307	189	12	1.7k
Jeffrey Kirshner United States	8	757 0.6×	605 1.1×	271 0.9×	158 0.5×	131 0.7×	10	1.4k
J.F. Lester United Kingdom	20	1.0k 0.9×	638 1.1×	150 0.5×	243 0.8×	192 1.0×	84	1.5k
D.A. Loblaw Canada	29	2.5k 2.1×	587 1.0×	306 1.0×	487 1.6×	307 1.6×	88	3.4k
Phillip Parente Australia	21	420 0.4×	698 1.2×	152 0.5×	147 0.5×	258 1.4×	82	1.5k
Larysa Rydzewska United Kingdom	16	1.0k 0.9×	317 0.6×	181 0.6×	377 1.2×	138 0.7×	33	1.5k
Thenappan Chandrasekar United States	22	1.0k 0.9×	407 0.7×	305 1.0×	198 0.6×	460 2.4×	130	1.7k
Som D. Mukherjee Canada	25	499 0.4×	968 1.7×	414 1.3×	136 0.4×	560 3.0×	85	2.0k
Lore Decoster Belgium	23	1.0k 0.9×	1.4k 2.4×	218 0.7×	241 0.8×	328 1.7×	102	2.8k
Brian F. Chapin United States	22	1.5k 1.3×	406 0.7×	349 1.1×	304 1.0×	345 1.8×	116	1.9k
Ubirajara Ferreira Brazil	22	1.8k 1.5×	345 0.6×	447 1.4×	370 1.2×	399 2.1×	132	2.6k

Countries citing papers authored by A. J. Neville

Since Specialization

Citations

This map shows the geographic impact of A. J. Neville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. J. Neville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. J. Neville more than expected).

Fields of papers citing papers by A. J. Neville

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. J. Neville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. J. Neville. The network helps show where A. J. Neville may publish in the future.

Co-authorship network of co-authors of A. J. Neville

This figure shows the co-authorship network connecting the top 25 collaborators of A. J. Neville. A scholar is included among the top collaborators of A. J. Neville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. J. Neville. A. J. Neville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Tam, Vincent C., Scott Berry, Tina Hsu, et al.. (2014). Oncology Education in Canadian Undergraduate and Postgraduate Medical Programs: A Survey of Educators and Learners. Current Oncology. 21(1). 75–88. 27 indexed citations

McKenzie, Michael, K. N., A. J. Neville, et al.. (2006). Phase II study of neoadjuvant docetaxel and androgen suppression (AS) plus radiation therapy (RT) for high-risk localized prostate cancer (HRLCaP). Journal of Clinical Oncology. 24(18_suppl). 4631–4631. 2 indexed citations

Dowling, Anthony, Tony Panzarella, D. Scott Ernst, et al.. (2001). A retrospective analysis of the relationship between changes in serum PSA, palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancer. Annals of Oncology. 12(6). 773–778. 17 indexed citations

Bloomfield, David, Murray Krahn, Tuhina Neogi, et al.. (1998). Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.. Journal of Clinical Oncology. 16(6). 2272–2279. 56 indexed citations

Cunnington, John, A. J. Neville, & Geoffrey R. Norman. (1996). The risks of thoroughness: Reliability and validity of global ratings and checklists in an OSCE. Advances in Health Sciences Education. 1(3). 227–233. 62 indexed citations

Neville, A. J., John Cunnington, & Geoffrey R. Norman. (1996). Development of clinical reasoning exercises in a problem-based curriculum. Academic Medicine. 71(1). S105–7. 15 indexed citations

Tannock, I. F., David Osoba, Martin R. Stockler, et al.. (1996). Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.. Journal of Clinical Oncology. 14(6). 1756–1764. 1202 indexed citations breakdown →

Moore, Malcolm J., David Osoba, Keefe Murphy, et al.. (1994). Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.. Journal of Clinical Oncology. 12(4). 689–694. 132 indexed citations

Neville, A. J. & Gajendra Singh. (1990). Effect of whole-body hyperthermia on hepatic cytochrome P450. Cancer Chemotherapy and Pharmacology. 25(5). 342–344. 2 indexed citations

10.

Neville, A. J. & Daniel N. Sauder. (1988). Whole body hyperthermia (41-42 degrees C) induces interleukin-1 in vivo.. PubMed. 7(3). 201–6. 31 indexed citations

11.

Remick, Scot C., A. J. Neville, & James K. V. Willson. (1987). Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.. PubMed. 71(6). 575–80. 7 indexed citations

12.

Robins, H. Ian, Warren H. Dennis, A. J. Neville, et al.. (1985). A nontoxic system for 41.8 degrees C whole-body hyperthermia: results of a Phase I study using a radiant heat device.. PubMed. 45(8). 3937–44. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact